ANALYSIS OF THE SHOPE-PAPILLOMA CARCINOMA SYSTEM
ANALYSIS OF THE SHOPE-PAPILLOMA CARCINOMA SYSTEM
批准号:
3481805
负责人:
FELIX O WETTSTEIN
金额:
$22.43万
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
已结题
起止时间:
1976-06-30 至 1995-06-30
关键词:
Shope papilloma affinity chromatography cocarcinogen density gradient ultracentrifugation gel electrophoresis genetic translation host neoplasm interaction immunochemistry immunofluorescence technique ion exchange chromatography laboratory rabbit molecular oncology nucleic acid hybridization nucleic acid sequence protein biosynthesis protein structure function rabbit papillomavirus simian virus 40 viral carcinogenesis virus DNA virus RNA virus genetics virus protein virus related neoplasm /cancer virus replication
中文摘要
我们已经通过S1和ExoVII酶切和引物进行了定位
无病毒家兔体内延伸病毒转录本的研究
家兔乳头状瘤、癌及病毒的产生
并测定它们的编码能力。少校
转录本可以编码E7和截短的E6蛋白,以及次要的
鉴定出了可以编码E2和全尺寸E6的基因
蛋白。所有早期的rna都是从带有tata的启动子转录而来的。
盒子。病毒特有的2.6和4.8kb的晚期转录本
产生L1和L2或可能的L2-L1的肿瘤编码
融合蛋白。这两个基因都有相同的先导外显子和一个CAPITE
位于未翻译区域中,该区域前面没有
塔塔箱。这表明从早到晚的切换
转录包括识别新的启动子和
转录终止在早期的抑制
多聚腺苷酸化位点。早期蛋白在COS-7细胞中的表达
使我们能够鉴定E6蛋白和初步数据
也获得了E2。人乳头瘤病毒16型DNA分析
宫颈癌已经表明,在大多数情况下,HPV-16DNA是
集成的。有些还含有质粒DNA。成绩单映射
表明E7和E6的主要转录本编码以及它
表明只有整合的DNA才是功能和整合的,
至少是一些DNA,可能是癌症进展所必需的。
HPV-16的E7蛋白已被鉴定为细胞质
半衰期短的磷蛋白。棉尾兔
乳头瘤病毒提供了唯一的动物模型系统和我们的
长期的目标是了解人类免疫缺陷病毒的分子生物学。
病毒,特别是病毒如何对
恶性肿瘤的发展。
在本申请中,我们建议:1)识别和
伊利病毒蛋白的生物化学特征
亚细胞分布、修饰、与细胞的关联
蛋白质和可能的酶活性;2)确定它们的
通过对动物和动物的遗传分析来实现生物学功能
上皮细胞培养;3)启动与以下相关的实验
免疫现象。
英文摘要
We have mapped by S1 and ExoVII digestion and by primer
extension viral transcripts in nonvirus producing domestic rabbit
papillomas and carcinomas and in virus producing domestic rabbit
papillomas and determined their coding capacity. The major
transcripts can code for E7 and a truncated E6 protein, and minor
ones were identified which can code for E2 and a full sized E6
protein. All early RNA is transcribed from promotors with TATA
boxes. Late transcripts of 2.6 and 4.8 kb unique to virus
producing tumors code for an L1 and an L2 or possibly an L2-L1
fusion protein. Both share the same leader exon and a capsite
located in the untranslated region which is not preceded by a
TATA box. This indicates that a switch from early to late
transcription involves recognition of a new promotor and
suppression of transcription termination at the early
polyadenylation site. Expression of early proteins in COS-7 cells
has permitted us to identify the E6 protein and preliminary data
have also been obtained for E2. DNA analysis of HPV-16 in
cervical cancer has shown that in a majority, the HPV-16 DNA is
integrated. Some also contain plasmid DNA. Transcript mapping
indicated that the major transcripts code for E7 and E6 and it
suggests that only integrated DNA is functional and integration,
at least of some DNA, may be required for cancer progression.
The E7 protein of HPV-16 has been identified as a cytoplasmic
phosphoprotein with a short half life. Cottontail rabbit
papillomavirus provides the only animal model system and our
long term objective is to understand the molecular biology of the
virus and particularly how the virus contributes to the
development of malignant tumors.
In the present application, we propose to: 1) Identify and
biochemically characterize ealy viral proteins with respect to
subcellular distribution, modification, association with cellular
proteins and possible enzymatic activity; 2) Determine their
biological function through a genetic analysis in animals and
epithelial cell culture; 3) Initiate experiments related to
immunologic phenomena.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF VACCINES AGAINST PAPILLOMAVIRUSES
-
批准号:3202227
-
项目类别:
-
资助金额:$10.07万
-
财政年份:1992
-
负责人:FELIX O WETTSTEIN
-
依托单位:
DEVELOPMENT OF VACCINES AGAINST PAPILLOMAVIRUSES
-
批准号:3202226
-
项目类别:
-
资助金额:$9.62万
-
财政年份:1992
-
负责人:FELIX O WETTSTEIN
-
依托单位:
DEVELOPMENT OF VACCINES AGAINST PAPILLOMAVIRUSES
-
批准号:2098640
-
项目类别:
-
资助金额:$10.27万
-
财政年份:1992
-
负责人:FELIX O WETTSTEIN
-
依托单位:
IMMUNOLOGY OF VIRUS INDUCED PAPILLOMAS/CARCINOMAS
-
批准号:3194750
-
项目类别:
-
资助金额:$28.25万
-
财政年份:1989
-
负责人:FELIX O WETTSTEIN
-
依托单位:
IMMUNOLOGY OF VIRUS INDUCED PAPILLOMAS/CARCINOMAS
-
批准号:2093716
-
项目类别:
-
资助金额:$29.35万
-
财政年份:1989
-
负责人:FELIX O WETTSTEIN
-
依托单位:
IMMUNOLOGY OF VIRUS INDUCED PAPILLOMAS/CARCINOMAS
-
批准号:3194749
-
项目类别:
-
资助金额:$27.14万
-
财政年份:1989
-
负责人:FELIX O WETTSTEIN
-
依托单位:
IMMUNOLOGY OF VIRUS INDUCED PAPILLOMAS/CARCINOMAS
-
批准号:3194748
-
项目类别:
-
资助金额:$26.51万
-
财政年份:1989
-
负责人:FELIX O WETTSTEIN
-
依托单位:
IMMUNOLOGY OF VIRUS INDUCED PAPILLOMAS/CARCINOMAS
-
批准号:3194746
-
项目类别:
-
资助金额:$25.87万
-
财政年份:1989
-
负责人:FELIX O WETTSTEIN
-
依托单位:
HUMAN PAPILLOMAVIRUSES IN GENITAL TRACT DYSPLASIAS
-
批准号:3182983
-
项目类别:
-
资助金额:$11.74万
-
财政年份:1986
-
负责人:FELIX O WETTSTEIN
-
依托单位:
HUMAN PAPILLOMAVIRUSES IN GENITAL TRACT DYSPLASIAS
-
批准号:3182987
-
项目类别:
-
资助金额:$12.21万
-
财政年份:1986
-
负责人:FELIX O WETTSTEIN
-
依托单位:
HUMAN PAPILLOMAVIRUSES IN GENITAL TRACT DYSPLASIAS
-
批准号:3182986
-
项目类别:
-
资助金额:$12.44万
-
财政年份:1986
-
负责人:FELIX O WETTSTEIN
-
依托单位:
ANALYSIS OF THE SHOPE-PAPILLOMA CARCINOMA SYSTEM
-
批准号:3481799
-
项目类别:
-
资助金额:$17.9万
-
财政年份:1976
-
负责人:FELIX O WETTSTEIN
-
依托单位:
ANALYSIS OF THE SHOPE-PAPILLOMA CARCINOMA SYSTEM
-
批准号:3481802
-
项目类别:
-
资助金额:$18.06万
-
财政年份:1976
-
负责人:FELIX O WETTSTEIN
-
依托单位:
ANALYSIS OF THE SHOPE-PAPILLOMA CARCINOMA SYSTEM
-
批准号:3481800
-
项目类别:
-
资助金额:$21.66万
-
财政年份:1976
-
负责人:FELIX O WETTSTEIN
-
依托单位:
ANALYSIS OF THE SHOPE-PAPILLOMA CARCINOMA SYSTEM
-
批准号:3481803
-
项目类别:
-
资助金额:$17.8万
-
财政年份:1976
-
负责人:FELIX O WETTSTEIN
-
依托单位:
ANALYSIS OF THE SHOPE PAPILLOMA-CARCINOMA SYSTEM
-
批准号:3164872
-
项目类别:
-
资助金额:$15.73万
-
财政年份:1976
-
负责人:FELIX O WETTSTEIN
-
依托单位:
ANALYSIS OF THE SHOPE PAPILLOMA-CARCINOMA SYSTEM
-
批准号:3164873
-
项目类别:
-
资助金额:$15.71万
-
财政年份:1976
-
负责人:FELIX O WETTSTEIN
-
依托单位:
ANALYSIS OF THE SHOPE-PAPILLOMA CARCINOMA SYSTEM
-
批准号:3481804
-
项目类别:
-
资助金额:$19.23万
-
财政年份:1976
-
负责人:FELIX O WETTSTEIN
-
依托单位:
ANALYSIS OF THE SHOPE-PAPILLOMA CARCINOMA SYSTEM
-
批准号:3481801
-
项目类别:
-
资助金额:$18.22万
-
财政年份:1976
-
负责人:FELIX O WETTSTEIN
-
依托单位:
ANALYSIS OF THE SHOPE-PAPILLOMA CARCINOMA SYSTEM
-
批准号:2086683
-
项目类别:
-
资助金额:$23.07万
-
财政年份:1976
-
负责人:FELIX O WETTSTEIN
-
依托单位:
海外基金